Publications by authors named "Sandeep Atla"

Claim this Profile
A
A Simple, Quick, and Scalable Route to Fluorogenic Ubiquitin and Ubiquitin-Like Protein Substrates for Assessing Activities of Deubiquitinases and Ubiquitin-Like Protein-Specific Proteases.
Saibal Chanda, Alan Pham, Yifan Shi, Sandeep Atla, Wenshe Ray Liu

ACS Chem Biol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ubiquitin Azapeptide Esters as Next-Generation Activity-Based Probes for Cysteine Enzymes in the Ubiquitin Signal Pathway.
Saibal Chanda, Sandeep Atla, Xinlei Sheng, Satyanarayana Nyalata, Yugendar R Alugubelli

J Am Chem Soc· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of NLRP3 inflammasome in nanoparticle adjuvant-mediated immune response.
Momitul Ahmed, Pavithra Kurungottu, K Swetha, Sandeep Atla, Nivethitha Ashok

Biomater Sci· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prioritization of Eleven-Nineteen-Leukemia Inhibitors as Orally Available Drug Candidates for Acute Myeloid Leukemia.
Xuejiao Shirley Guo, Sandeep Atla, Satyanarayana Nyalata, Yugendar R Alugubelli, Peng-Hsun Chase Chen

J Med Chem· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors.
Kaustav Khatua, Yugendar R Alugubelli, Kai S Yang, Veerabhadra R Vulupala, Lauren R Blankenship, Sandeep Atla

Antiviral Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main Protease.
Yugendar R Alugubelli, Jing Xiao, Kaustav Khatua, Sathish Kumar, Long Sun, Sandeep Atla

J Med Chem· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main Protease.
Yugendar R Alugubelli, Jing Xiao, Kaustav Khatua, Sathish Kumar, Yuying Ma, Sandeep R Atla

bioRxiv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease.
Zhi Zachary Geng, Sandeep Atla, Namir Shaabani, Veerabhadra Vulupala, Kai S Yang

J Med Chem· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Azapeptide Platform in Conjunction with Covalent Warheads to Uncover High-Potency Inhibitors for SARS-CoV-2 Main Protease.
Kaustav Khatua, Yugendar R Alugubelli, Kai S Yang, Veerabhadra R Vulupala, Lauren R Blankenship, Sandeep Atla

bioRxiv· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease.
Zhi Zachary Geng, Sandeep Atla, Namir Shaabani, Veerabhadra R Vulupala, Kai S Yang

bioRxiv· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis